Signal Peptide Database - Mammalia

 Entry Details
ID   155
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   Q61330    (Created: 2001-04-27 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name   CNTN2_MOUSE
Protein Name   Contactin-2
Gene   Cntn2
Organism Scientific   Mus musculus
Organism Common   Mouse
Lineage   Eukaryota
  Metazoa
    Chordata
      Craniata
        Vertebrata
          Euteleostomi
            Mammalia
              Eutheria
                Euarchontoglires
                  Glires
                    Rodentia
                      Sciurognathi
                        Muroidea
                          Muridae
                            Murinae
                              Mus
Protein Length [aa]   1040
Protein Mass [Da]   113217
Features  
TypeDescriptionStatusStartEnd
signal peptide      by similarity   1   30
chain   Contactin-2      31   1014
disulfide bond      by similarity   63   113
disulfide bond      by similarity   157   209
disulfide bond      by similarity   263   308
disulfide bond      by similarity   350   397
domain   Ig-like C2-type 1      39   130
domain   Ig-like C2-type 2      135   224
domain   Ig-like C2-type 3      241   324
domain   Ig-like C2-type 4      329   413
domain   Ig-like C2-type 5      419   506
domain   Ig-like C2-type 6      511   605
domain   Fibronectin type-III 1      609   705
domain   Fibronectin type-III 2      712   809
domain   Fibronectin type-III 3      814   910
domain   Fibronectin type-III 4      914   1004
glycosylation site   N-linked (GlcNAc...)   potential   78   78
glycosylation site   N-linked (GlcNAc...)   potential   200   200
glycosylation site   N-linked (GlcNAc...)   potential   206   206
glycosylation site   N-linked (GlcNAc...)   potential   463   463
glycosylation site   N-linked (GlcNAc...)   potential   479   479
glycosylation site   N-linked (GlcNAc...)   potential   500   500
glycosylation site   N-linked (GlcNAc...)   potential   527   527
glycosylation site   N-linked (GlcNAc...)   potential   777   777
glycosylation site   N-linked (GlcNAc...)   potential   832   832
glycosylation site   N-linked (GlcNAc...)   potential   920   920
glycosylation site   N-linked (GlcNAc...)   potential   942   942
propeptide   Removed in mature form   potential   1015   1040
compositionally biased region   Gly/Pro-rich      608   614
short sequence motif   Cell attachment site   potential   796   798
lipid moiety-binding region   GPI-anchor amidated serine   potential   1014   1014
SP Length   30
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MGAPARKRASLLLLLLATMALVSSPGWSFS
Sequence MGAPARKRASLLLLLLATMALVSSPGWSFSQGTPATFGPVFEEQPVGLLF
PEESAEDQVTLACRARASPPATYRWKM
NGTEMNLEPGSRHQLMGGNLVIM
SPTKAQDAGVYQCLASNPVGTVVSKEAVLR
FGFLQEFSKEERDPVKTHEG
WGVMLPCNPPAHYPGLSYRWLLNEFPNFIPTDGRHFVSQTTGNLYIART
N
ASDLGNYSCLATSHLDFSTKSVFSKFAQLNLAAEDPRLFAPSIKARFPPE
TYALVGQQVTLECFAFGNPVPRIKWRKVDGSLSPQWGTAEPTLQIPSVSF
EDEGTYECEAENSKGRDTVQGRII
VQAQPEWLKVISDTEADIGSNLRWGC
AAAGKPRPMVRWLRNGEPLASQNRVEVLAGDLRFSKLNLEDSGMYQCVAE
NKHGTIYASAELA
VQALAPDFRQNPVRRLIPAARGGEISIPCQPRAAPKA
TILWSKGTEILG
NSTRVTVTLDGTLIIRNISRSDEGKYTCFAENFMGKAN
STGILSVRDATKITLAPSSADINVGDNLTLQCHASHDPTMDLTFTWTLDD
FPVDFDKPGGHYRRASVKETIGDLTILNAQLRHGGTYTCMAQTVVDGASK
EATVL
VRGPPGPPGGVVVRDIGDTTVQLSWSRGFDNHSPIAKYTLQARTP
PSGKWKQVRTNPVNIEGNAETAQVLGLMPWMDYEFRVSASNILGTGEPSG
PSSRI
RTKEAVPSVAPSGLSGGGGAPGELTINWTPMSREYQNGDGFGYLL
SFRRQGSSSWQTARVPGADTQYFVYS
NDSIHPYTPFEVKIRSYNRRGDGP
ESLTAIVYS
AEEEPKVAPAKVWAKGSSSSEMNVSWEPVLQDMNGILLGYE
IRYWKAGDKEAAADRVRTAGLDSSARVTGLYPNTKYHVTVRAYNRAGTGP
ASPSADAMTM
KPPPRRPPGNISWTFSSSSLSLKWDPVVPLRNESTVTGYK
MLYQNDLQPTPMLHLTSKNWIEIPVPEDIGHALVQIRTTGPGGDGIPAEV
HIVR
NGGTSMMVESSAVRPAHPGPVFSCMVILMLAGCQRL
Original MGAPARKRASLLLLLLATMALVSSPGWSFSQGTPATFGPVFEEQPVGLLF
PEESAEDQVTLACRARASPPATYRWKMNGTEMNLEPGSRHQLMGGNLVIM
SPTKAQDAGVYQCLASNPVGTVVSKEAVLRFGFLQEFSKEERDPVKTHEG
WGVMLPCNPPAHYPGLSYRWLLNEFPNFIPTDGRHFVSQTTGNLYIARTN
ASDLGNYSCLATSHLDFSTKSVFSKFAQLNLAAEDPRLFAPSIKARFPPE
TYALVGQQVTLECFAFGNPVPRIKWRKVDGSLSPQWGTAEPTLQIPSVSF
EDEGTYECEAENSKGRDTVQGRIIVQAQPEWLKVISDTEADIGSNLRWGC
AAAGKPRPMVRWLRNGEPLASQNRVEVLAGDLRFSKLNLEDSGMYQCVAE
NKHGTIYASAELAVQALAPDFRQNPVRRLIPAARGGEISIPCQPRAAPKA
TILWSKGTEILGNSTRVTVTLDGTLIIRNISRSDEGKYTCFAENFMGKAN
STGILSVRDATKITLAPSSADINVGDNLTLQCHASHDPTMDLTFTWTLDD
FPVDFDKPGGHYRRASVKETIGDLTILNAQLRHGGTYTCMAQTVVDGASK
EATVLVRGPPGPPGGVVVRDIGDTTVQLSWSRGFDNHSPIAKYTLQARTP
PSGKWKQVRTNPVNIEGNAETAQVLGLMPWMDYEFRVSASNILGTGEPSG
PSSRIRTKEAVPSVAPSGLSGGGGAPGELTINWTPMSREYQNGDGFGYLL
SFRRQGSSSWQTARVPGADTQYFVYSNDSIHPYTPFEVKIRSYNRRGDGP
ESLTAIVYSAEEEPKVAPAKVWAKGSSSSEMNVSWEPVLQDMNGILLGYE
IRYWKAGDKEAAADRVRTAGLDSSARVTGLYPNTKYHVTVRAYNRAGTGP
ASPSADAMTMKPPPRRPPGNISWTFSSSSLSLKWDPVVPLRNESTVTGYK
MLYQNDLQPTPMLHLTSKNWIEIPVPEDIGHALVQIRTTGPGGDGIPAEV
HIVRNGGTSMMVESSAVRPAHPGPVFSCMVILMLAGCQRL
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11